Downloadable

CONNECT Trial Infographic

A visual summary of CONNECT trial results for Dexcom CGM in type 2 diabetes not treated with insulin.

Image
CONNECT Trial Infographic - 1200x1200

This resource is intended for educational purposes only for healthcare providers practicing in the United States. It does not constitute medical advice and is not a substitute for professional judgment or individualized patient care.

Evidence summaries for real-world care

CONNECT Trial Infographic

Download for easy reference, printing, or sharing with your care team.

References

  • Martens, T. Presented at American Diabetes Association 2026 Scientific Sessions, June 6, 2026; New Orleans, LA; USA.
  • Reed J, Dong T, Eaton E, et al. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial. Diabetes Obes Metab. 2024;26(7):2881-2889. doi:10.1111/dom.15608
  • Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care. 2019;42(3):400-405. doi:10.2337/dc18-1444
  • Shah VN, Kanapka LG, Akturk HK, et al. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes Technol Ther. 2024;26(4):246-251. doi:10.1089/dia.2023.0486
  • Kovatchev BP, Lobo B, Fabris C, et al. The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications. Diabetes Technol Ther. 2025;27(3):209-216. doi:10.1089/dia.2024.0404